Cannabis Guidance Comments
- CCSS
- Sep 23, 2020
- 1 min read
Comments from the Collaborative for CBD Science and Safety on “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research” (FDA-2020-D-1079)
Click here to view the PDF.
Comments